VRXAW
Veraxa Biotech AG - Post de-SPACWarrants of Veraxa Biotech AG - Post de-SPAC · VRXA stock page →
—
Market cap
$4.5M
Nano cap
1 year
−90.7%
from $10.49 · Oct 27
30 days
−28.5%
from $1.37
52-week range
$0.9800–24.79
at the low
Avg volume 20D
293.6K
Oct 9 spike 1.86M
Short interest
🔒 Subscribers only
Price
Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.
No data for this timeframe.
- X Sep 15 Short interest jumps 290.4% to 1.6K
Signal stack
Where each data set points today.
- TrendDOWNTREND
30% below its 50-day average. New closing low $0.9800 on Oct 26.
Who's buying
13F| Top holder | Shares | Value |
|---|---|---|
| UBS Group AG | 1 | $0.00 |
| LMR Partners LLP | 1,089,100 | $120.1K |
| Magnetar Financial LLC | 1,055,078 | $116.4K |
| Alberta Investment Management Corp | 875,000 | $96.5K |
| Clear Street Group Inc. | 485,358 | $53.5K |
| JPMORGAN CHASE & CO | 350,256 | $43.8K |
| BNP PARIBAS FINANCIAL MARKETS | 253,207 | $27.9K |
| MILLENNIUM MANAGEMENT LLC | 200,000 | $22.1K |
Quarterly 13F filings are due 45 days after each quarter ends.
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | — | — | — | $0.00 |
| Next Q | — | — | — | $0.00 |
| Current FY | — | — | — | $0.00 |
| Next FY | — | — | — | $0.00 |
Short side
FINRA· Oct 15, 2026🔒 Subscribers only
shares short